FDA Inspection 1020396 — Minaris Regenerative Medicine, LLC
The FDA completed an inspection of Minaris Regenerative Medicine, LLC on Apr 26, 2017 in Allendale, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 26, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Allendale, NJ (United States)